Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Jun 4;8(7):bvae107.
doi: 10.1210/jendso/bvae107. eCollection 2024 May 23.

The Loss of Estradiol by Androgen Deprivation in Prostate Cancer Patients Shows the Importance of Estrogens in Males

Affiliations
Review

The Loss of Estradiol by Androgen Deprivation in Prostate Cancer Patients Shows the Importance of Estrogens in Males

Herjan J T Coelingh Bennink et al. J Endocr Soc. .

Abstract

The role of estradiol (E2; an estrogen) in men needs to be more appreciated. In this review, we address the clinical situations that allow the study of the clinical consequences of E2 deficiency in men and discuss the effects of restoration of levels of this reproductive steroid hormone. In men with advanced prostate cancer (PCa) undergoing androgen deprivation therapy (ADT), E2 is suppressed along with testosterone, leading to side effects affecting the quality of life. These include hot flashes, arthralgia, fatigue, mood changes, cognition problems, weight gain, bone loss, and increased risk of cardiovascular disease. Transdermal E2 alone for ADT has shown equivalent testosterone suppression compared to gonadotropin-releasing hormone (GnRH) agonists while also preventing estrogen-deficiency side effects, including hot flashes and bone loss. Co-treatment of ADT with fetal estrogen estetrol (E4) has shown significant improvements of estrogen-deficiency symptoms. These observations emphasize the need to raise awareness of the importance of estrogens in men among clinicians and the lay public.

Keywords: androgen deprivation therapy (ADT); bone loss; estetrol (E4); estrogen deficiency symptoms; hot flashes; transdermal estradiol (tE2).

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Mean levels of estradiol (E2 pg/mL), progesterone (P4 ng/mL), and testosterone (T pg/mL) during a normal menstrual cycle of 28 days, and corresponding E2 levels in postmenopausal women and in men (red bar) and T levels in men (blue bar). Original figure (sources: Frederiksen et al 2020, and Penell et al 2021) [11, 12].
Figure 2.
Figure 2.
Median levels of (A) total testosterone, (B) free testosterone, and (C) prostate-specific antigen (PSA) after 2, 4, 6, 8, 12, 18, and 24 weeks of treatment with 40 mg estetrol (E4) or placebo in patients with prostate cancer treated with a GnRH agonist [6]. Note: E2, estradiol; P4, progesterone; T, testosterone. Adapted from Coelingh Bennink et al 2021 (reproduced according to BY-NC-ND 4.0) [6].

Similar articles

Cited by

References

    1. Parker C, Castro E, Fizazi K, et al. . Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2020;31(9):1119‐1134. - PubMed
    1. Mohler JL, Antonarakis ES, Armstrong AJ, et al. . Prostate cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2019;17(5):479‐505. - PubMed
    1. Freedland SJ, Eastham J, Shore N. Androgen deprivation therapy and estrogen deficiency induced adverse effects in the treatment of prostate cancer. Prostate Cancer Prostatic Dis. 2009;12(4):333‐338. - PubMed
    1. Coelingh Bennink HJT, Krijgh J, Egberts JF, et al. . Maintaining bone health by estrogen therapy in patients with advanced prostate cancer: a narrative review. Endocr Connect. 2022;11(12):e220182. - PMC - PubMed
    1. Pencina KM, Travison TG, Cunningham GR, et al. . Effect of testosterone replacement therapy on sexual function and hypogonadal symptoms in men with hypogonadism. J Clin Endocrinol Metab. 2024;109(2):569‐580. - PubMed

LinkOut - more resources